These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9857872)

  • 41. Ketanserin in the treatment of protamine-induced pulmonary hypertension.
    van der Starre PJ; Solinas C
    Tex Heart Inst J; 1996; 23(4):301-4. PubMed ID: 8969033
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of heparinase I in a patient with protamine allergy undergoing redo myocardial revascularization.
    Ralley FE; De Varennes B
    J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):710-1. PubMed ID: 11139116
    [No Abstract]   [Full Text] [Related]  

  • 43. Cardiac arrest following protamine administration.
    Chung F; Miles J
    Can Anaesth Soc J; 1984 May; 31(3 Pt 1):314-8. PubMed ID: 6722622
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.
    Yamamoto T; Wolf HG; Sinzobahamvya N; Asfour B; Hraska V; Schindler E
    Thorac Cardiovasc Surg; 2015 Aug; 63(5):397-403. PubMed ID: 26121380
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protamine-associated hypotension in patients on hemodialysis: retrospective study and prevalence of antiprotamine antibodies.
    Tsai YT; Chang LC; Lin YF; Tsai CS; Lai CH; Chen JS
    Clin Nephrol; 2009 Aug; 72(2):122-8. PubMed ID: 19640369
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The use of nitric oxide for managing catastrophic pulmonary vasoconstriction arising from protamine administration.
    Ralley FE
    Anesth Analg; 1999 Mar; 88(3):505-7. PubMed ID: 10071995
    [No Abstract]   [Full Text] [Related]  

  • 47. Fatal anaphylactoid shock associated with protamine for heparin reversal during anesthesia.
    Peng CH; Tan PH; Lin CH; Lin HY; Kuo CH; Chung HC
    Acta Anaesthesiol Sin; 2000 Jun; 38(2):97-102. PubMed ID: 11000674
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An Adjusted Calculation Model Allows for Reduced Protamine Doses without Increasing Blood Loss in Cardiac Surgery.
    Kjellberg G; Sartipy U; van der Linden J; Nissborg E; Lindvall G
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):487-93. PubMed ID: 26270199
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extracorporeal immunoadsorption in heparin- and protamine-induced thrombocytopaenia prior to cardiac surgery.
    Füreder L; Böhmig GA; Schaefer AK; Steinlechner B
    Eur J Cardiothorac Surg; 2019 Jul; 56(1):206-207. PubMed ID: 30541064
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Life threatening protamine reaction during bypass surgery--a case report.
    Mishra DK; Sathyamurthy I; Subramanyan K; Girinath MR
    Indian Heart J; 2009; 61(2):216-7. PubMed ID: 20039513
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protamine reaction in a patient undergoing coronary artery bypass grafting.
    Hughes C; Haddock M
    CRNA; 1995 Nov; 6(4):172-6. PubMed ID: 8680346
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hemodynamic changes during protamine administration.
    Michaels IA; Barash PG
    Anesth Analg; 1983 Sep; 62(9):831-5. PubMed ID: 6603799
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery?
    Teoh KH; Young E; Blackall MH; Roberts RS; Hirsh J
    J Thorac Cardiovasc Surg; 2004 Aug; 128(2):211-9. PubMed ID: 15282457
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protamine-Induced Coronary Graft Thrombosis: A Review.
    Chandiramani AS; Jenkin I; Botezatu B; Harky A
    J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt A):2679-2684. PubMed ID: 34774407
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hemodynamics of protamine administration. Comparison of right atrial, left atrial, and aortic injections.
    Katz NM; Kim YD; Siegelman R; Ved SA; Ahmed SW; Wallace RB
    J Thorac Cardiovasc Surg; 1987 Dec; 94(6):881-6. PubMed ID: 3682857
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The successful management of severe protamine-induced pulmonary hypertension using inhaled prostacyclin.
    Jerath A; Srinivas C; Vegas A; Brister S
    Anesth Analg; 2010 Feb; 110(2):365-9. PubMed ID: 19933533
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Complement activation by heparin-protamine complexes during cardiopulmonary bypass: effect of C4A null allele.
    Shastri KA; Logue GL; Stern MP; Rehman S; Raza S
    J Thorac Cardiovasc Surg; 1997 Sep; 114(3):482-8. PubMed ID: 9305203
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A prospective study of the risk of an immediate adverse reaction to protamine sulfate during cardiopulmonary bypass surgery.
    Weiler JM; Gellhaus MA; Carter JG; Meng RL; Benson PM; Hottel RA; Schillig KB; Vegh AB; Clarke WR
    J Allergy Clin Immunol; 1990 Apr; 85(4):713-9. PubMed ID: 2182695
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protamine Administration Via the Ascending Aorta May Prevent Cardiopulmonary Instability.
    Chaney MA; Devin Roberts J; Wroblewski K; Shahul S; Gaudet R; Jeevanandam V
    J Cardiothorac Vasc Anesth; 2016 Jun; 30(3):647-55. PubMed ID: 26948466
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heparin and protamine titration do not improve haemostasis in cardiac surgical patients.
    Shore-Lesserson L; Reich DL; DePerio M
    Can J Anaesth; 1998 Jan; 45(1):10-8. PubMed ID: 9466020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.